Counterpoint: Epidemiology to Guide Decision-Making: Moving Away From Practice-Free Research

American Journal of Epidemiology

Volumn 182, Issue 10, 2015, Pages 834-839

  Hernán, Miguel A ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

causal inference; decision making; left truncation; survival curves

Indexed keywords

ESTROGEN; GESTAGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

DECISION MAKING; DISEASE TREATMENT; EPIDEMIOLOGY; GROWTH CURVE; RESEARCH WORK; STRATEGIC APPROACH; STUDY METHOD; SURVIVAL;

ALTERNATIVE MEDICINE; DECISION MAKING; EPIDEMIOLOGY; FOLLOW UP; HAZARD RATIO; HORMONAL THERAPY; HUMAN; INFORMATION; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT; POLICY; PRACTICE FREE RESEARCH; RESEARCH; REVIEW; SURVIVAL RATE; CAUSALITY; METHODOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL BIAS; TIME FACTOR;

BIAS (EPIDEMIOLOGY); CAUSALITY; DECISION MAKING; EPIDEMIOLOGIC METHODS; FOLLOW-UP STUDIES; HUMANS; OBSERVATIONAL STUDIES AS TOPIC; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TIME FACTORS;

EID: 84947545296     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwv215     Document Type: Review

References (31)

1. Vandenbroucke J, Pearce N. Point: Incident exposures, prevalent exposures, and causal inference: Does limiting studies to persons who are followed from first exposure onward damage epidemiology? Am J Epidemiol. 2015;182(10):826-833.
2. Feinstein AR. Clinical biostatistics. XI. Sources of 'chronology bias' in cohort statistics. Clin Pharmacol Ther. 1971;12(5):864-879.
3. Feinstein AR. Sources of 'chronology bias'. In: Clinical Biostatistics. St. Louis, MO: The C. V. Mosby Company; 1977:89-104.
4. Rubin DB. Estimating causal effects of treatments in randomized and nonrandomized studies. J Educ Psychol. 1974;66(5):688-701.
5. Rubin DB. Bayesian inference for causal effects: the role of randomization. Ann Statist. 1978;6(1):34-58.
6. Robins JM. Addendum to "a new approach to causal inference in mortality studies with a sustained exposure period - application to control of the healthy worker survivor effect" [published errata appear in Comput Math Appl. 1989;18:477]. Comput Math Appl. 1987;14:923-945.
7. Robins JM. A new approach to causal inference in mortality studies with a sustained exposure period - application to control of the healthy worker survivor effect [published errata appear in Math Model. 1987;14:917-921]. Math Model. 1986;7:1393-1512.
8. Robins JM. A graphical approach to the identification and estimation of causal parameters in mortality studies with sustained exposure periods. J Chronic Dis. 1987;40(suppl 2):139S-161S.
9. Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003;158(9):915-920.
10. Hernán MA. With great data comes great responsibility: publishing comparative effectiveness research in epidemiology. Epidemiology. 2011;22(3):290-291.
11. Galea S. An argument for a consequentialist epidemiology. Am J Epidemiol. 2013;178(8):1185-1191.
12. Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 2003;349(6):523-534.
13. Hernán MA, Alonso A, Logan R, et al. Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology. 2008;19(6):766-779.
14. Hernán MA. The hazards of hazard ratios. Epidemiology. 2010;21(1):13-15.
15. Cole SR, Hudgens MG, Brookhart MA, et al. Risk. Am J Epidemiol. 2015;181(4):246-250.
16. Danaei G, Tavakkoli M, Hernán MA. Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins. Am J Epidemiol. 2012;175(4):250-262.
17. Suissa S. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol. 2008;167(4):492-499.
18. Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;360(18):1815-1826.
19. Hernán MA, Robins JM. Early versus deferred antiretroviral therapy for HIV. N Engl J Med. 2009;361(8):822-823; author reply 823-824.
20. Hernán MA, Hernández-Díaz S, Werler MM, et al. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol. 2002;155(2):176-184.
21. Lajous M, Banack HR, Kaufman JS, et al. Should patients with chronic disease be told to gain weight? The obesity paradox and selection bias. Am J Med. 2015;128(4):334-336.
22. Hernán MA, Alonso A, Logroscino G. Cigarette smoking and dementia: potential selection bias in the elderly. Epidemiology. 2008;19(3):448-450.
23. Hernán MA, Taubman SL. Does obesity shorten life? The importance of well-defined interventions to answer causal questions. Int J Obes (Lond). 2008;32(suppl 3):S8-S14.
24. Glass TA, Goodman SN, Hernán MA, et al. Causal inference in public health. Annu Rev Public Health. 2013;34:61-75.
25. Feinstein AR, Horwitz RI. A critique of the statistical evidence associating estrogens with endometrial cancer. Cancer Res. 1978;38(11 pt 2):4001-4005.
26. Greenland S, Rothman KJ, Lash TL. Measures of effect and measures of association. In: Rothman KJ, Greenland S, Lash TL, eds. Modern Epidemiology. 3rd ed. Philadelphi, PA: Lippincott, Williams & Wilkins; 2008:51-70.
27. Greenland S, Rothman KJ. Measures of occurrence. In: Rothman KJ, Greenland S, Lash TL, eds. Modern Epidemiology. 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2008:32-50.
28. Lajous M, Willett WC, Robins J, et al. Changes in fish consumption in midlife and the risk of coronary heart disease in men and women. Am J Epidemiol. 2013;178(3):382-391.
29. Pearl J. Causal diagrams for empirical research. Biometrika. 1995;82(4):669-710.
30. Spirtes P, Glymour C, Scheines R. Causation, Prediction and Search. 2nd ed. Cambridge, MA: MIT Press; 2000.
31. Hernán MA. Invited commentary: Agent-based models for causal inference-reweighting data and theory in epidemiology. Am J Epidemiol. 2015;181(2):103-105.